info@ease-med-control.com
Partnering
We combine the drive and ambitions of a startup management with the advanced research of our scientists. Our wide-ranging research tool box includes next generation sequencing, cloning, isolation of rare autoimmune cells, isolation and cloning of autoimmune antibodies and T cell receptors, computational biology and artificial intelligence/machine learning. At the lab we use experimental transgenic and knockout mouse models of various chronic diseases. We also use metabolomics/proteomics/lipidomics, advanced microscopy/imaging technologies, tissue clearing techniques and translational research into human diseases. Through our collaboration with lead institutions, such as the German Center for Cardiovascular Research, Munich Heart Alliance, the Center for Neuropathology and Prion Research, LMU and Munich Cluster of Systems Neurology - to name just a few in our home-base in Munich. With our international collaborators in various research consortia, we also have access to resources of human tissues including human brain banks and cardiovascular tissue banks, drug screening technologies, and structural biology tools to accelerate the development of therapeutic programs and discovery technologies.
We envision initiating new collaborations. Our areas of interest are based around understanding the basic biology of aging as well as therapeutical interventions to treat age-related chronic diseases. We are flexible regarding how we structure our partnerships. We are looking to engage in collaborative research programs, sponsored academic investigations, strategic alliances and collaboration with pharmaceutical companies, as well as licensing of our proprietary discoveries for therapeutic programs and drug development.
We envision initiating new collaborations. Our areas of interest are based around understanding the basic biology of aging as well as therapeutical interventions to treat age-related chronic diseases. We are flexible regarding how we structure our partnerships. We are looking to engage in collaborative research programs, sponsored academic investigations, strategic alliances and collaboration with pharmaceutical companies, as well as licensing of our proprietary discoveries for therapeutic programs and drug development.
If you would like to collaborate with Easemedcontrol, please provide us with a non-confidential proposal that describes the opportunity, including scientific supporting data to:
info@ease-med-control.com.
Partner with us
